Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Drug Policy. 2010 May;21(3):229-33. doi: 10.1016/j.drugpo.2009.10.005. Epub 2009 Nov 18.

Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine.

Author information

  • 1Research Institute for Public Health and Addiction, Konradstrasse 32, 8031 Zurich, Switzerland. michael.schaub@isgf.uzh.ch

Abstract

BACKGROUND:

Opioid substitution therapy (OST) in the Ukraine was not provided until 2004. Methadone maintenance therapy only became available in May 2008. Injecting drug users in Ukraine are predominantly injecting self-made opioid solution ('Shirka'). A feasibility study on buprenorphine and methadone maintenance treatment was conducted in 2008.

METHODS:

A total of 331 opioid dependent patients were given buprenorphine (n=191) or methadone (n=140) as a substitute, and a survey of substance use, HIV transmission risks, and legal and social status was conducted at baseline and at six months follow-up.

RESULTS:

Illegal substance use, illegal activities, incomes and HIV related transmission risks were highly reduced, whereas employment rates and psychiatric problems improved. Retention was comparatively high among the patients in buprenorphine (84.8%) and in methadone maintenance treatment (85.0%) after six months of treatment.

CONCLUSION:

These data show the successful implementation of OST in the Ukraine among drug users who were predominantly injectors of self-made opioid solutions. Continuing scale-up of OST in the Ukraine is therefore both feasible and highly recommended.

Copyright 2009 Elsevier B.V. All rights reserved.

PMID:
19926271
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk